Concepedia

Publication | Open Access

Hydroxyurea Compared with Anagrelide in High-Risk Essential Thrombocythemia

DOIFull Paper Access

910

Citations

27

References

2005

Year

Claire Harrison, Peter J. Campbell, Georgina Buck, Keith Wheatley, Clare East, D. Bareford, Bridget S. Wilkins, Jon van der Walt, John T. Reilly, Andrew Grigg,
New England Journal of Medicine

Abstract

Hydroxyurea plus low-dose aspirin is superior to anagrelide plus low-dose aspirin for patients with essential thrombocythemia at high risk for vascular events.

References

YearCitations

Page 1